期刊文献+

利妥昔单抗联合CHOP方案治疗淋巴瘤引起间质性肺炎5例及文献复习 被引量:2

下载PDF
导出
摘要 利妥昔单抗(商品名:美罗华)联合CHOP方案治疗CD20^+弥漫大B细胞淋巴瘤(DLBCL)的完全缓解率达61%~76%,目前R—CHOP方案在CD20^+B细胞淋巴瘤治疗中已成为标准一线方案。
出处 《徐州医学院学报》 CAS 2013年第12期894-896,共3页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献11

  • 1Coiffier B,Lepage E,Briere J. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma[J].{H}New England Journal of Medicine,2003,(4):235-242.
  • 2Ram R,Ben Bassat I,Shpilberg O. The late adverse events of rituximab therapy--rare but there![J].{H}Leukemia & lymphoma,2009,(7):1083-1095.doi:10.1080/10428190902934944.
  • 3Subramanian M,Manjunath R,Kilara N. Rituximab-induced subacute interstitial pneumonitis:A case report and review of literature[J].{H}JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,2010,(3):344-346.
  • 4Zayen A,Rais H,Rifi H. Rituximab-induced interstitial lung disease:case report and literature review[J].{H}PHARMACOLOGY,2011,(5-6):318-320.
  • 5Katsuya H,Suzumiya J,Sasaki H. Addition of rituximab to cyclophosphamide,doxorubicin,vincristine,and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma[J].{H}Leukemia & lymphoma,2009,(11):1818-1823.
  • 6冯艺,周宇红.利妥昔单抗联合CHOP化疗方案治疗B细胞非霍奇金淋巴瘤感染病例观察[J].中国临床医学,2010,17(6):889-891. 被引量:11
  • 7Cha SI,Choi KJ,Shin KM. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma[J].{H}RESPIRATION,2013,(2):175.
  • 8Lim KH,Yoon HI,Kang YA. Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide,doxorubicin,vincristine,and prednisone (CHOP) regimen plus rituximab[J].{H}Korean Journal of Internal Medicine,2010,(1):86-92.
  • 9Huang YC,Liu CJ,Liu CY. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma[J].{H}Annals of Hematology,2011,(10):1145-1151.
  • 10Macartney C,Burke E,Elborn S. Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim[J].{H}Leukemia & lymphoma,2005,(10):1523-1526.

二级参考文献11

  • 1Coiffier B,Lepage E,Briere J,et al.CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.[J] N Engl J Med,2003,346:235-242.
  • 2Burton C,Kaczmarski R,Jan-Mohamed R.Interstitial pneumonitis related to rituximab therapy.[J] N Engl J Med,2003,348:2690-2691.
  • 3Satio B,Nakamaki T,Adachi D,et al.Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma.[J] Int J Hematol,2004,80:164-167.
  • 4Swords R,Power D,Fay M,et al.Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (itp).[J] Am J Hematol,2004,77:103-104.
  • 5Hiraga J,Kondoh Y,Taniguchi H,et al.A case of interstitial pneumonia induced by rituximab therapy.[J] Int J Hematol,2005,81:169-170.
  • 6Herishanu Y,Polliack A,Leider-Trejo L,et al.Fatal interstitial pneumonitis related to rituximab-containing regimen.[J] Clin Lymphoma Myeloma,2006,6:407-409.
  • 7Mellstedt H.Monoclonal antibodies in human cancer.[J] Drug Today (Barc),2003,39 Suppl C:1-16.
  • 8Vose JM,Link BK,Grossbard ML,et al.PhaseⅡstudy of rituximab in combination with CHOP chemotherapy in patients with previously untreated aggressive non-Hodgkin's lymphoma[J].J Clin Oncol,2001,19:389-397.
  • 9Daisuke E,Yasuhito T,Masahiro Y,et al.Increased incidence of interstitial pneumonia by CHOP combined with rituximab.[J] Int J Hematol,2008,87:393-397.
  • 10Cornely OA,Ullmann AJ,Karthaus M.[Opportunistic infection after treatment with monoclonal antibodies].[J] Wien Med Wochenschr,2004,154:209-217.

共引文献10

同被引文献15

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部